Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Pharma can't win with critics, even when it makes breakthroughs
Ist Teil von
Medical Marketing and Media, 2019-05, Vol.54 (5), p.54-54
Ort / Verlag
New York: Haymarket Media, Inc
Erscheinungsjahr
2019
Link zum Volltext
Quelle
EBSCOhost Business Source Ultimate
Beschreibungen/Notizen
A few months ago, 60 Minutes aired a segment about an investigational gene therapy that may have the potential to cure sickle cell anemia - a scourge that afflicts about 100,000 Americans, most of whom are African-American or Hispanic. If a cure for sickle cell anemia, or Alzheimer's or Parkinson's or the dreaded disease of your choice, is eventually approved, you'll see an entirely different 60 Minutes segment. Instead of lauding how patients are being saved from a devastating genetic disease, this story will begin like this: "We have just learned that XYZ pharma company plans to rip off the healthcare system by charging hundreds of thousands of dollars for a treatment that was basically invented by the government."